To estimate the side effects of chemotherapy and the influence of age
at the time of nephrectomy on renal function, we investigated renal fu
nction in 34 uninephrectomised children with neuroblastoma (NB) or Wil
ms' tumour (WT). The results were compared with 6 controls who underwe
nt nephrectomy for non-malignant disease. Study of renal function was
primarily based on the clearance of inulin and para-aminohippuric acid
C-in and C-PAH, ml/min per 1.73 m(2)). No significant differences in
C-in/C-PAH (mean +/- SD) were found between the NE group (90 +/- 24/ 4
21 +/- 95), WT group (85 +/- 17/386 +/- 104) and the controls (93 +/-
13/430 +/- 61). Children with NE and WT were divided into two subgroup
s according to the theoretical nephrotoxic risk. There was no signific
ant difference in renal function between NE or between WT subgroups. C
umulative cisplatin doses in children with NE did not affect renal fun
ction significantly. The age at time of unilateral nephrectomy (less t
han or equal to 2 years vs. > 2 years) was not associated with a highe
r risk of renal damage in WT children, whereas in NE children the filt
ration fraction (C-in:C-PAH) was higher in younger children (mean +/-
SD: 0.243 +/- 0.023 vs. 0.191 +/- 0.041). In conclusion, uninephrectom
ised children with NE are supposed to have a higher risk of drug-induc
ed renal impairment compared with those with WT. Our data do not confi
rm this hypothesis, since renal function was comparable to controls in
both groups, except in younger patients with NE who show a high filtr
ation fraction. Since the survival of children with NE has improved, a
longer follow-up of their renal function in needed.